TipRanks
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market
IBRX
ImmunityBio
RESEARCH TOOLSreports
Want to see IBRX full AI Analyst Report?

ImmunityBio (IBRX) Stock News & Sentiment

2,584 Followers
ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential
Premium
Company Announcements
ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential
7d ago
IBRX
ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should Know
Premium
Company Announcements
ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should Know
8d ago
IBRX
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
Premium
Market NewsSponsored
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
9d ago
BE
MU
ImmunityBio (IBRX) Faces Investor Scrutiny as Defendants Move to Dismiss Securities Lawsuit Over Podcast Statements
Premium
Class Action
ImmunityBio (IBRX) Faces Investor Scrutiny as Defendants Move to Dismiss Securities Lawsuit Over Podcast Statements
9d ago
IBRX
BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
Premium
Ratings
BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
2M ago
IBRX
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
Premium
Ratings
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
2M ago
IBRX
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
Premium
Company Announcements
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
2M ago
8K
IBRX
More IBRX News >

IBRX News on the Web

A $5.8B Cancer Market Opportunity Is Emerging — Why GA-Courtenay Favors ImmunityBio (IBRX)
Insider Monkey
Bullish
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
TipRanks News
Neutral
ImmunityBio Stock Sinks as Speculative Rally Unravels
TipRanks News
Neutral
ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%
Insider Monkey
Bullish
ImmunityBio Soars On New Trial Tease And Expansion Hopes
TipRanks News
Bullish
Is ImmunityBio Inc (IBRX) Worth the Investment? Q2 Revenue Surges to $50.7 Million Amid $230. ...
GuruFocus News
Neutral
Biotech High‑Flyer ImmunityBio Suddenly Hits a Wall
TipRanks News
Neutral
Insider Stock Sale Sends ImmunityBio Shares Sinking
TipRanks News
Neutral

News Score - Last 7 Days

Positive
IBRX
Sector Average
Media Buzz
This Week4 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IBRX’s Media Buzz Sentiment?
4 articles about IBRX were published this week. In an average week, 4 articles are published.
    What is IBRX’s weekly average amount of articles?
    In an average week, 4 articles about IBRX are published.
      What is IBRX’s News Sentiment?
      100% of articles about IBRX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SYRESpyre Therapeutics
        BAYRYBayer
        QTTBQ32 Bio
        CICigna
        ZYMEZymeworks
        Showing the stocks with the most bullish news sentiment over the past week